BRIEF-Fulgent Genetics Q4 Revenue USD 76.214 Million

Reuters
28 Feb
BRIEF-Fulgent Genetics Q4 Revenue USD 76.214 Million

Feb 28 (Reuters) - Fulgent Genetics Q4 pretax profit USD -8.045 million.

  • Q4 operating expenses USD 47.984 million
  • Q4 operating income USD -16.135 million
  • Q4 gross profit USD 31.849 million
  • Q4 core revenue USD 76 million
  • Q4 adjusted EBITDA USD 800 thousand

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10